Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Rui Xiong; Leike Zhang; Shiliang Li; Yuan Sun; Minyi Ding; Yong Wang; Yongliang Zhao; Yan Wu; Weijuan Shang; Xiaming Jiang; Jiwei Shan; Zihao Shen; Yi Tong; Liuxin Xu; Yu Chen; Yingle Liu; Gang Zou; Dimitri Lavillete; Zhenjiang Zhao; Rui Wang; Lili Zhu; Gengfu Xiao; Ke Lan; Honglin Li; Ke Xu

ArticleOPEN ACCESS

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Protein and Cell

DOI: 10.1007/s13238-020-00792-w

2Citations

11Readers

Abstract

In the original publication there are few errors in Figure 1. The correct Figure 1 is provided in this correction

Cite

CITATION STYLE

APA

Xiong, R., Zhang, L., Li, S., Sun, Y., Ding, M., Wang, Y., … Xu, K. (2021, January 1). Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w). Protein and Cell. Higher Education Press Limited Company. https://doi.org/10.1007/s13238-020-00792-w

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Abstract

Cite

Register to see more suggestions